News

A phase 2 clinical trial of our drug, squaric acid dibutyl ester, has opened at Massachusetts General Hospital and Stanford University. This is a placebo-controlled double-blind clinical trial in persons with frequent cold sores aimed at providing further evidence of efficacy of the drug in preventing cold sores.